Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SAGE - Sage Therapeutics Q4 2021 Earnings Preview

SAGE - Sage Therapeutics Q4 2021 Earnings Preview

Sage Therapeutics Inc.
Sage Therapeutics (NASDAQ:SAGE) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open. The consensus EPS Estimate is -$2.16 and the consensus Revenue Estimate is $1.77M (-99.8% Y/Y). Over the last 1 year, SAGE has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 0 upward revisions and 2 downward. In December 2021, Sage Therapeutics and Biogen reported positive zuranolone data in a late-stage depression study.

For further details see:

Sage Therapeutics Q4 2021 Earnings Preview
Stock Information
Company Name: Sage Therapeutics Inc.
Stock Symbol: SAGE
Market: NASDAQ
Website: sagerx.com
Menu
SAGE SAGE Quote SAGE Short SAGE News SAGE Articles SAGE Message Board
Get SAGE Alerts

News, Short Squeeze, Breakout and More Instantly...